The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis

BACKGROUND: The rationale for additional treatment with short-acting bronchodilators combined with long-acting bronchodilators for patients with chronic obstructive pulmonary disease (COPD) is not adequately studied. METHODS: We conducted a systematic review and meta-analysis to evaluate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanimura, Kazuya, Sato, Susumu, Fujita, Yukio, Yamamoto, Yoshifumi, Hajiro, Takashi, Horita, Nobuyuki, Kawayama, Tomotaka, Muro, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052583/
https://www.ncbi.nlm.nih.gov/pubmed/36967224
http://dx.doi.org/10.1177/14799731231166008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052583/
https://www.ncbi.nlm.nih.gov/pubmed/36967224
http://dx.doi.org/10.1177/14799731231166008

Ejemplares similares